Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 5 , Pages 799-806 , May 2008

Repeated Treatments With Botulinum Toxin Type A Produce Sustained Decreases in the Limitations Associated With Focal Upper-Limb Poststroke Spasticity for Caregivers and Patients

Presented in part to the American Academy of Physical Medicine and Rehabilitation, October 27–30, 2005, Philadelphia, PA; and the International Conference on the Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, June 23–25, 2005, Denver, CO.

  • Elie P. Elovic, MD

      Affiliations

    • Kessler Medical Rehabilitation Research and Education Center, West Orange, NJ
    • Department of Physical Medicine and Rehabilitation UMDNJ-NJ Medical School, Newark, NJ
    • Corresponding Author InformationReprint requests to Elie P. Elovic, MD, 1199 Pleasant Valley Way, West Orange, NJ, 07052
    • ,
  • Allison Brashear, MD

      Affiliations

    • Department of Neurology, Wake Forest University, Winston-Salem, NC
    • ,
  • Darryl Kaelin, MD

      Affiliations

    • Acquired Brain Injury Program, Shepherd Center, Atlanta, GA
    • ,
  • Jingyu Liu, PhD

      Affiliations

    • Allergan Inc, Irvine, CA.
    • ,
  • Scott R. Millis, PhD

      Affiliations

    • School of Medicine, Wayne State University, Detroit, MI
    • ,
  • Richard Barron, MS

      Affiliations

    • Allergan Inc, Irvine, CA.
    • ,
  • Catherine Turkel, PharmD, MBA

      Affiliations

    • Allergan Inc, Irvine, CA.

 Supported by Allergan Inc.

 A commercial party having a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit upon the author or one or more of the authors. Elovic has received grant funding from Allergan and Merz, is on the speakers bureau of Allergan, and is on the advisory boards of Allergan, Merz, and Solstice. Brashear has received grant funding from Allergan, Merz, Solstice, and Ipsen and has a consulting agreement with Allergan and Merz. Kaelin has received grant funding from Allergan and is on the speakers bureau of Allergan. Liu was an employee of Allergan and had stock in Allergan at the time the study was conducted. Barron was an employee of Allergan and had stock options in Allergan at the time the study was conducted. Turkel is an employee of Allergan and has both stock and stock options in Allergan. Merz and Ipsen manufacture botulinum toxin type A; Solstice manufactures botulinum toxin type B.

PII: S0003-9993(08)00082-8

doi: 10.1016/j.apmr.2008.01.007

Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 5 , Pages 799-806 , May 2008

Article Tools

* Image Usage & Resolution